Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-425255
Filing Date
2013-11-04
Accepted
2013-11-04 16:19:59
Documents
5
Period of Report
2013-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d622563d6k.htm 6-K 10655
2 EX-99.1 d622563dex991.htm EX-99.1 12678
3 GRAPHIC g622563g26p14.jpg GRAPHIC 228960
4 GRAPHIC g622563g29n49.jpg GRAPHIC 42018
5 GRAPHIC g622563g92l05.jpg GRAPHIC 197540
  Complete submission text file 0001193125-13-425255.txt   670246
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 131189359
SIC: 2834 Pharmaceutical Preparations